Palbociclib capsules 125 mg
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Palbociclib capsules 125 mg contain palbociclib, a CDK4/6 inhibitor. Its labelling describes it for the treatment of breast cancer — specifically estrogen receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative disease — given in combination with other hormonal anticancer therapies. It is described as stopping the responsible chemicals so that it arrests the cancer cell cycle and targets estrogen receptor-positive breast cancer cells.
Product Information
The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of estrogen receptor-positive, HER2-negative breast cancer
- Described as given in combination with other hormonal anticancer therapies
- Described as arresting the cancer cell cycle and targeting estrogen receptor-positive breast cancer cells
Described Dosage & Administration
- Taken with food, preferably at the same time every day, following the doctor’s instructions and completing the full duration
- A missed dose is skipped; a regular schedule should be followed and the dose should never be doubled
- Driving should be avoided after taking the medicine
Described Side Effects
Commonly described side effects include:
- Fatigue and weakness
- Hair loss
- Rash
- Nausea and vomiting
- Diarrhoea
- Decreased appetite
- Infection
- Anaemia
- Fever
- Decreased white blood cell count
These are described as commonly temporary. The doctor should be consulted if they persist.
Precautions
- Effective contraception should be used during the medication
- The doctor should be told about any plans for future pregnancy
- Driving should be avoided after taking the medicine
- Any persistent side effect should be reported to the doctor
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains palbociclib and is used for the treatment of estrogen receptor-positive, HER2-negative breast cancer, given with hormonal anticancer therapy. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as taken with food at the same time every day, following the doctor’s instructions; a missed dose is skipped rather than doubled and the full duration should be completed.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.